Subscribe To
Pds biotechnology: speculative biotech worth buying after latest data
Positive results were announced from the phase 2 NCI-led PDS0101 triple-combination study in patients with HPv...
May 27, 2022, 1:36 pm
Piper comments on increased interest to invest in arcturus, 'incrementally positive' on argenx
Piper Sandler noted that Arcturus Therapeutics Holdings Inc's (NASDAQ: ARCT) recently filed 10-K mentions funding of $25 million from a "pharmaceut...
March 22, 2022, 3:58 pm
Ese entertainment introduces its new esports team, k1ck cs:go
ESE Entertainment Inc. (TSX-V:ESE) announced that its K1CK Esports team has revealed a new roster for a Counter-Strike Global Offensive (CS:GO) team. ...
March 17, 2022, 8:48 am
Regencell bioscience's covid-19 candidate shows encouraging action on mild to moderate symptoms
Regencell Bioscience Holdings Limited (NASDAQ: RGC) announced the results from the EARTH efficacy trial of its COVID-19 candidate. RGC-CO...
February 17, 2022, 11:40 am
Regencell bioscience's covid-19 candidate shows encouraging action on mild to moderate symptoms
Regencell Bioscience Holdings Limited (NASDAQ: RGC) announced the results from the EARTH efficacy trial of its COVID-19 candidate. RGC-CO...
February 17, 2022, 11:40 am
Regencell bioscience's covid-19 candidate shows encouraging action on mild to moderate symptoms
Regencell Bioscience Holdings Limited (NASDAQ: RGC) announced the results from the EARTH efficacy trial of its COVID-19 candidate. RGC-CO...
February 17, 2022, 11:40 am
Enveric biosciences advancing clinical plans as it announces two new molecules to treat osteoarthritis and other pain conditions
Enveric Biosciences (NASDAQ:ENVB) said that two new molecules, Ev104a and E...
February 8, 2022, 8:55 am
Enveric biosciences advancing clinical plans as it announces two new molecules to treat osteoarthritis and other pain conditions
Enveric Biosciences (NASDAQ:ENVB) said that two new molecules, Ev104a and E...
February 8, 2022, 8:55 am
Enveric biosciences advancing clinical plans as it announces two new molecules to treat osteoarthritis and other pain conditions
Enveric Biosciences (NASDAQ:ENVB) said that two new molecules, Ev104a and E...
February 8, 2022, 8:55 am
Enveric biosciences files provisional patent for cbd+celecoxib conjugate for osteoarthritis
Psychedelics-based neuroscience company Enveric Biosciences (NASDAQ: ENVB) announced the development of Ev1<...
February 8, 2022, 8:30 am
Enveric biosciences files provisional patent for cbd+celecoxib conjugate for osteoarthritis
Psychedelics-based neuroscience company Enveric Biosciences (NASDAQ: ENVB) announced the development of Ev1<...
February 8, 2022, 8:30 am
Enveric biosciences files provisional patent for cbd+celecoxib conjugate for osteoarthritis
Psychedelics-based neuroscience company Enveric Biosciences (NASDAQ: ENVB) announced the development of Ev1<...
February 8, 2022, 8:30 am
Bmw starts final run of v12 combustion engines for 7 series
The v12 has been surpassed by pure EV powertrains as the symbol of luxury at BMW, and the engine will q...
January 24, 2022, 11:58 am
Bmw starts final run of v12 combustion engines for 7 series
The v12 has been surpassed by pure EV powertrains as the symbol of luxury at BMW, and the engine will q...
January 24, 2022, 11:58 am
Bmw starts final run of v12 combustion engines for 7 series
The v12 has been surpassed by pure EV powertrains as the symbol of luxury at BMW, and the engine will q...
January 24, 2022, 11:58 am
Daré bioscience's one-time bacterial vaginosis treatment scores fda approval
The FDA has approved Daré Bioscience Inc (NASDAQ: DARE) Xaciato (DARE-Bv1) to treat bacterial vagin...
December 7, 2021, 1:07 pm
Daré bioscience's one-time bacterial vaginosis treatment scores fda approval
The FDA has approved Daré Bioscience Inc (NASDAQ: DARE) Xaciato (DARE-Bv1) to treat bacterial vagin...
December 7, 2021, 1:07 pm
Daré bioscience's one-time bacterial vaginosis treatment scores fda approval
The FDA has approved Daré Bioscience Inc (NASDAQ: DARE) Xaciato (DARE-Bv1) to treat bacterial vagin...
December 7, 2021, 1:07 pm
Sqz biotechnologies' cell therapy shows favorable safety profile in hpv+ solid tumors
SQZ Biotechnologies Company (NYSE: SQZ) announced interim results from the highest-dose monotherapy cohort of Phase 1/2 trial of SQZ-PBMC-HPV in Hu...
December 2, 2021, 1:31 pm
Sqz biotechnologies' cell therapy shows favorable safety profile in hpv+ solid tumors
SQZ Biotechnologies Company (NYSE: SQZ) announced interim results from the highest-dose monotherapy cohort of Phase 1/2 trial of SQZ-PBMC-HPV in Hu...
December 2, 2021, 1:31 pm